Incyte
INCY
#1012
Rank
NZ$41.22 B
Marketcap
NZ$203.36
Share price
-2.82%
Change (1 day)
59.22%
Change (1 year)

Market capitalization of Incyte (INCY)

Market cap: NZ$41.22 Billion

As of August 2026 Incyte has a market cap of NZ$41.22 Billion. This makes Incyte the world's 1012th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Incyte from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$41.22 B21.47%
2025NZ$33.93 B43.5%
2024NZ$23.64 B6.28%
2023NZ$22.25 B-20.94%
2022NZ$28.14 B18.57%
2021NZ$23.73 B-10.09%
2020NZ$26.39 B-5.81%
2019NZ$28.02 B38.63%
2018NZ$20.21 B-28.16%
2017NZ$28.14 B3.2%
2016NZ$27.26 B-7.8%
2015NZ$29.57 B85.49%
2014NZ$15.94 B58.78%
2013NZ$10.04 B272.64%
2012NZ$2.69 B10.93%
2011NZ$2.42 B-8.2%
2010NZ$2.64 B77.45%
2009NZ$1.49 B134.98%
2008NZ$0.63 B-42.78%
2007NZ$1.10 B59.33%
2006NZ$0.69 B6.58%
2005NZ$0.65 B-43.81%
2004NZ$1.16 B52.27%
2003NZ$0.76 B30.41%
2002NZ$0.58 B-81.27%
2001NZ$3.12 B-15.26%
2000NZ$3.68 B11.18%
1999NZ$3.31 B68.04%
1998NZ$1.97 B5.82%
1997NZ$1.86 B144.92%
1996NZ$0.76 B

End of Day market cap according to different sources

On Aug 1st, 2026 the market cap of Incyte was reported to be:

NZ$41.22 Billion
by Nasdaq info icon info icon
NZ$41.22 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$504.99 B 1,125.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$242.53 B 488.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.743 T 4,128.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$353.69 B 758.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$9.80 B-76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$1.40 B-96.58%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ$2.03 B-95.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
NZ$0.88 B-97.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$2.08 B-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA